Skip to main content
SpringerLink
Log in

Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Maffini E, Storer BE, Sandmaier BM, Bruno B, Sahebi F, Shizuru JA, et al. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. Haematologica. 2019;104:380–91.

    Article  CAS  Google Scholar 

  2. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.

    Article  Google Scholar 

  3. Montefusco V, Mussetti A, Rezzonico F, Maura F, Pennisi M, de Philippis C, et al. Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients. Bone Marrow Transpl. 2017;52:1602–8.

    Article  CAS  Google Scholar 

  4. Patriarca F, Einsele H, Spina F, Bruno B, Isola M, Nozzoli C, et al. Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability. Biol Blood Marrow Transpl. 2012;18:617–26.

    Article  CAS  Google Scholar 

  5. Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, et al. Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Am J Hematol. 2013;88:581–8.

    Article  Google Scholar 

  6. Dhakal B, D’Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, et al. Allogeneic hematopoietic cell transplantation in multiple myeloma: impact of disease risk and post allograft minimal residual disease on survival. Clin Lymphoma Myeloma Leuk. 2016;16:379–86.

    Article  Google Scholar 

  7. Crawley C, Lalancette M, Szydlo R, Gilleece M, Peggs K, Mackinnon S, et al. Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. Blood. 2005;105:4532–9.

    Article  CAS  Google Scholar 

  8. Gagelmann N, Eikema DJ, Koster L, Caillot D, Pioltelli P, Lleonart JB, et al. Tandem Autologous stem cell transplantation improves outcomes in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the chronic malignancies working party of the european society for blood and marrow transplantation. Biol Blood Marrow Transplant. 2019. https://doi.org/10.1016/j.bbmt.2019.07.004. [Epub ahead of print].

Download references

Author information

Authors and Affiliations

  1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Salvatore Fiorenza & Jordan Gauthier

  2. Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia

    David Routledge, Jenny Collins, Simon Harrison, Ashish Bajel & David Ritchie

  3. The Christie NHS Foundation Trust, Manchester, UK

    Michael Shipton & James Cavet

  4. Central Manchester NHS Foundation Trust, Manchester, UK

    Eleni Tholouli

Authors
  1. Salvatore Fiorenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Routledge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jenny Collins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Shipton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Simon Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ashish Bajel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James Cavet
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eleni Tholouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jordan Gauthier
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David Ritchie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jordan Gauthier or David Ritchie.

Ethics declarations

Conflict of interest

The authors declare that they have no relevant conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Results presented in part at 59th American Society of Hematology Annual Meeting, 2017

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiorenza, S., Routledge, D., Collins, J. et al. Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma. Bone Marrow Transplant 55, 1172–1174 (2020). https://doi.org/10.1038/s41409-019-0642-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-019-0642-x

  • Springer Nature Limited

This article is cited by

Search

Navigation